IntrinsicIntrinsic
← All summaries

AstroNova, Inc.

ALOT
Financials & Chart →

Business Summary

AstroNova, Inc. operates in the specialty printing and data acquisition and analysis systems industry, designing, developing, manufacturing, and distributing products that incorporate advanced technologies to acquire, store, analyze, and present data in multiple formats. Target markets include aerospace, apparel, automotive, aviation, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. The company sells its products worldwide through its own sales force, authorized dealers, and independent dealers and representatives. During fiscal 2026, the company sold products to customers in over 90 countries.

The company believes it is a market leader in tabletop digital color label printing technology in the specialty on-demand printing field, the market leader in flight deck printers, and an innovator in digital color mini-press systems. In the data acquisition area, the company is one of the leaders in general-purpose, portable, high-speed data acquisition systems. The company retains its leadership position by virtue of its proprietary technology, product reputation, delivery, channels to market, technical assistance, and service to customers. Key competitive factors include technology, quality, service and support, distribution network, and breadth of product and service offerings. The company utilizes 145 independent dealers and representatives selling and marketing its products in approximately 60 countries. No single customer accounted for 10% or more of net revenue in any of the last three fiscal years.

The company generates revenue through two segments: Product Identification (Product ID) and Aerospace. The Product ID segment generates revenue from specialty printing systems and related supplies, including hardware, software, and consumables like ink, toner, labels, and tags. The Aerospace segment generates revenue from aerospace printers, Ethernet networking products, and test and measurement data acquisition systems, as well as related services, repairs, and supplies. The business model includes both hardware sales and recurring revenue from supplies and services. Customers include brand owners, commercial printers, OEMs, and various industries requiring data visualization and printing solutions.

The Product ID segment offers digital color label tabletop printers, light commercial label printers, direct-to-package printers, high-volume presses, and specialty OEM printing systems under the QuickLabel, TrojanLabel, AstroJet, and GetLabels brand names. It also offers a broad range of label, tag, and other supplies, including ink and toner. Products attributable to the May 2024 MTEX acquisition are mid-to-high volume direct-to-package printers and label printers targeting the industrial and commercial printing segments. The segment also provides worldwide training and support and develops and licenses specialized software programs. Revenue from the Product ID segment was $104,221,000 in fiscal 2026, $102,345,000 in fiscal 2025, and $104,041,000 in fiscal 2024. Segment operating loss was $472,000 in fiscal 2026, compared to a loss of $11,859,000 in fiscal 2025 and a profit of $5,325,000 in fiscal 2024.

The Aerospace segment includes flight deck printing solutions, networking hardware, and certified thermal paper, as well as data acquisition systems used in research and development, flight testing, missile/rocket telemetry, production monitoring, and power and maintenance applications. Products include the ToughWriter series of airborne printers, ToughSwitch Ethernet switches, and data acquisition systems like the TMX, Daxus DXS-100, SmartCorder DDX-100, and Everest EV-5000. At the end of fiscal 2026, over 80% of the airborne printers sold were ToughWriter branded. Revenue from the Aerospace segment was $46,294,000 in fiscal 2026, $48,938,000 in fiscal 2025, and $44,045,000 in fiscal 2024. Segment operating profit was $9,763,000 in fiscal 2026, $9,087,000 in fiscal 2025, and $8,240,000 in fiscal 2024.

On May 4, 2024, the company entered into an agreement to acquire MTEX New Solution, S.A., a Portugal-based manufacturer of digital printing equipment, for closing consideration of EUR 17.3 million (approximately $18.7 million) . The acquisition closed on May 6, 2024, and MTEX is reported as part of the Product ID segment. On March 20, 2025, the company announced restructuring actions for fiscal 2026, which included reducing approximately 10% of the company's global workforce, primarily in the Product ID segment, and the realignment of the MTEX operation in Portugal. As part of this initiative, the company eliminated approximately 70% of the MTEX product portfolio. As of January 31, 2026, the company had incurred $1,400,000 in restructuring charges, primarily related to severance. The restructuring actions resulted in approximately $3,000,000 in annualized savings. On October 31, 2025, the company entered into a Sixth Amendment to its credit agreement with Bank of America, which increased the revolving credit facility commitment from $25,000,000 to $27,500,000 until July 31, 2026, after which it will reduce to $25,000,000 , and extended the maturity date of the revolving credit facility to August 4, 2028 . The amendment also refinanced existing term loans into a new Term Loan of $10,000,000 and a new Term A-2 Loan of $9,720,000 . On April 7, 2026, the company announced that its board of directors will perform a review and evaluation of strategic alternatives to maximize shareholder value.

Net revenue for fiscal 2026 was $150,515,000 , a 0.5% decrease compared to net revenue of $151,283,000 for fiscal 2025. Gross profit was $47,634,000 for fiscal 2026, reflecting a $3,024,000 or 6.0% decrease compared to fiscal 2025 gross profit of $50,658,000 . The gross profit margin was 31.6% in fiscal 2026, declining 190 basis points compared to the fiscal 2025 gross profit margin of 33.5% . Net loss for fiscal 2026 was $2,376,000 , or $0.31 per diluted share, compared to a net loss of $14,489,000 , or $1.93 per diluted share, in fiscal 2025. Net cash provided by operating activities was $11,738,000 in fiscal 2026 compared to $4,848,000 in the prior year.

Business Outlook

Management expects the Product ID segment to benefit from continued momentum in its North America Desktop business, expanded channel partnerships, and increased focus on higher-value capital equipment, which are expected to drive growth in recurring supplies revenue. These initiatives, together with targeted operational improvements, are expected to support improved execution, subject to tariff-related and supply chain risks. The company believes that the next generation print engine technology will enhance its other Product ID offerings and that the TRAX Machine Monitoring software acquired may be integrated into other products to improve the customer experience by maximizing machine uptime and support the use of only authentic AstroNova approved consumables.

Management expects the Aerospace segment to benefit from increasing commercial aircraft production rates, rising aircraft utilization, and expanded service opportunities, supporting measured growth in future periods. Profitability is expected to improve due to a more favorable product mix and the anticipated cessation of certain royalty obligations. The company is currently supplying ToughWriter printers for a range of commercial and business aircraft platforms including those manufactured by Airbus, Boeing, Embraer, Lockheed, Gulfstream, and others. In fiscal 2025, the company transitioned the Boeing 737 platform to ToughWriter printers, and in fiscal 2026, completed the transition of the Airbus A320 platform to ToughWriter printers.

The company's restructuring actions resulted in approximately $3,000,000 in annualized savings, and the company anticipates completing the plan by the second quarter of fiscal 2027. The company is continually reviewing its operations with a view towards reducing its cost structure including, but not limited to, reducing its labor cost-to-revenue ratio, improving process and system efficiencies, and outsourcing certain internal functions. In both fiscal 2026 and fiscal 2024, the company engaged in restructuring actions to reduce its cost structure in its Product ID segment.

The company maintains an active program of product research and development. It spent approximately $6,788,000 in fiscal 2026, $6,047,000 in fiscal 2025, and $6,341,000 in fiscal 2024, on company-sponsored product development. The company is committed to continuous product development as essential to its organic growth and expects to continue its focus on research and development efforts in fiscal 2027 and beyond. The company also continues to invest in sales and marketing initiatives by expanding and improving the existing sales force and using various marketing campaigns.

Capital expenditures were $332,000 in fiscal 2026, compared to $1,165,000 in fiscal 2025. The company did not repurchase any shares under a publicly announced plan during the fourth quarter of fiscal 2026. The company's credit agreement with Bank of America includes a revolving credit facility with a commitment of $27,500,000 until July 31, 2026, after which it will reduce to $25,000,000 . As of January 31, 2026, $15,700,000 was borrowed and outstanding under the revolving credit facility and $11,800,000 was available for borrowing. The company also has a secured equipment loan facility with an outstanding balance of $500,000 at January 31, 2026.

The company faces headwinds from changes to United States tariff and import/export regulations and potential countermeasures, which could increase costs and disrupt the global supply chain. During calendar year 2025, the U.S. government utilized the International Emergency Economic Powers Act to impose additional tariffs on a broad range of imports. As a result of mitigation actions, tariff rates on both direct imports and domestic purchases did not materially impact financial results in fiscal 2026. The tariff environment remains dynamic, and any rate increases or expansions of tariff coverage affecting the products sold could have a substantial impact on the business and on customers' budgets. The company also faces risks related to recession, inflation, stagflation, and other economic conditions, which could impact customer demand.

The company faces constraints from the integration of the MTEX acquisition, which has been more time-consuming and resource-intensive than originally anticipated. In the course of integrating MTEX, the company discovered certain facts that it believes may constitute breaches of the representations and warranties included in the definitive agreements governing the acquisition. The company and the seller have initiated arbitration in Portugal against one another. The company also faces risks related to its substantial indebtedness, which as of January 31, 2026, totaled $37,700,000 in outstanding debt. This includes $34,800,000 under the credit agreement with Bank of America, consisting of $15,700,000 under the revolving credit facility, a Term Loan of $9,500,000 , and a Term A-2 Loan of $9,600,000 , as well as $500,000 under a secured equipment facility and $2,400,000 of debt assumed as part of the MTEX acquisition.

Risk Factors

The company faces material risks from its substantial indebtedness, which totaled $37,700,000 as of January 31, 2026, including $34,800,000 under its credit agreement with Bank of America. The credit agreement contains financial covenants, including a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio, and failure to comply could materially adversely affect the business. The company also faces significant risks related to the integration of the MTEX acquisition, for which it recorded a goodwill impairment charge of $13,403,000 in fiscal 2025 and $297,000 in fiscal 2026, totaling $13,700,000 related to the acquisition. The company and the seller have initiated arbitration in Portugal, with the seller asserting claims for damages in the amount of Euro 5.2 million ($6.1 million as of January 31, 2026) and the company asserting counterclaims for damages of Euro 22.3 million ($26.2 million as of January 31, 2026) . Changes to United States tariff and import/export regulations pose a risk, as the company's mitigation actions prevented material impact in fiscal 2026, but the tariff environment remains dynamic and could substantially impact the business. The company relies on single-source or limited-source suppliers for certain components, including printheads for both segments, and any interruption in supply could materially adversely affect the business.

Management Priorities

Management's message in the filing reflects a focus on navigating a challenging period marked by the integration of the MTEX acquisition, restructuring actions, and a review of strategic alternatives. The tone is forward-looking and emphasizes operational improvements, cost reduction, and a commitment to maximizing shareholder value. Key strategic priorities include completing the restructuring plan, which is expected to generate approximately $3,000,000 in annualized savings and be completed by the second quarter of fiscal 2027, improving the performance of the Product ID segment through continued momentum in the North America Desktop business and expanded channel partnerships, and capitalizing on growth in the Aerospace segment from increasing commercial aircraft production rates and rising aircraft utilization. Management also highlights the importance of the review and evaluation of strategic alternatives announced on April 7, 2026, which may include a sale of all or part of the company, a merger, or other strategic transactions.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Marketing and Competition
  2. [2] Item 1, Business — Marketing and Competition
  3. [3] Item 7, MD&A — Results of Operations
  4. [4] Item 7, MD&A — Results of Operations
  5. [5] Item 7, MD&A — Segment Analysis
  6. [6] Item 7, MD&A — Segment Analysis
  7. [7] Item 7, MD&A — Segment Analysis
  8. [8] Item 7, MD&A — Segment Analysis
  9. [9] Item 1, Business — Product Overview
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Segment Analysis
  13. [13] Item 7, MD&A — Segment Analysis
  14. [14] Item 7, MD&A — Segment Analysis
  15. [15] Item 7, MD&A — Segment Analysis
  16. [16] Item 1, Business — General
  17. [17] Item 7, MD&A — Overview
  18. [18] Item 7, MD&A — Segment Analysis
  19. [19] Item 7, MD&A — Overview
  20. [20] Item 7, MD&A — Overview
  21. [21] Item 7, MD&A — Liquidity and Capital Resources
  22. [22] Item 7, MD&A — Liquidity and Capital Resources
  23. [23] Item 7, MD&A — Liquidity and Capital Resources
  24. [24] Item 7, MD&A — Liquidity and Capital Resources
  25. [25] Item 7, MD&A — Liquidity and Capital Resources
  26. [26] Item 7, MD&A — Liquidity and Capital Resources
  27. [27] Item 7, MD&A — Results of Operations
  28. [28] Item 7, MD&A — Results of Operations
  29. [29] Item 7, MD&A — Results of Operations
  30. [30] Item 7, MD&A — Results of Operations
  31. [31] Item 7, MD&A — Results of Operations
  32. [32] Item 7, MD&A — Results of Operations
  33. [33] Item 7, MD&A — Results of Operations
  34. [34] Item 7, MD&A — Results of Operations
  35. [35] Item 7, MD&A — Results of Operations
  36. [36] Item 7, MD&A — Results of Operations
  37. [37] Item 7, MD&A — Results of Operations
  38. [38] Item 7, MD&A — Results of Operations
  39. [39] Item 7, MD&A — Results of Operations
  40. [40] Item 7, MD&A — Results of Operations
  41. [41] Item 7, MD&A — Cash Flow
  42. [42] Item 7, MD&A — Cash Flow
  43. [43] Item 7, MD&A — Overview
  44. [44] Item 7, MD&A — Overview
  45. [45] Item 7, MD&A — Overview
  46. [46] Item 7, MD&A — Overview
  47. [47] Item 7, MD&A — Cash Flow
  48. [48] Item 7, MD&A — Cash Flow
  49. [49] Item 7, MD&A — Liquidity and Capital Resources
  50. [50] Item 7, MD&A — Liquidity and Capital Resources
  51. [51] Item 7, MD&A — Liquidity and Capital Resources
  52. [52] Item 7, MD&A — Liquidity and Capital Resources
  53. [53] Item 7, MD&A — Liquidity and Capital Resources
  54. [54] Item 1A, Risk Factors — Financial and Economic Risks
  55. [55] Item 1A, Risk Factors — Financial and Economic Risks
  56. [56] Item 1A, Risk Factors — Financial and Economic Risks
  57. [57] Item 1A, Risk Factors — Financial and Economic Risks
  58. [58] Item 1A, Risk Factors — Financial and Economic Risks
  59. [59] Item 1A, Risk Factors — Financial and Economic Risks
  60. [60] Item 1A, Risk Factors — Financial and Economic Risks
  61. [61] Item 1A, Risk Factors — Financial and Economic Risks
  62. [62] Item 1A, Risk Factors — Financial and Economic Risks
  63. [63] Item 1A, Risk Factors — Business and Industry Risks
  64. [64] Item 1A, Risk Factors — Business and Industry Risks
  65. [65] Item 1A, Risk Factors — Financial and Economic Risks
  66. [66] Item 3, Legal Proceedings
  67. [67] Item 3, Legal Proceedings
  68. [68] Item 7, MD&A — Overview
  69. [69] Item 8, Consolidated Statements of Income (Loss)
  70. [70] Item 8, Consolidated Statements of Income (Loss)
  71. [71] Item 8, Consolidated Statements of Income (Loss)
  72. [72] Item 8, Consolidated Statements of Income (Loss)
  73. [73] Item 8, Consolidated Statements of Income (Loss)
  74. [74] Item 8, Consolidated Statements of Income (Loss)
  75. [75] Item 8, Consolidated Statements of Income (Loss)
  76. [76] Item 8, Consolidated Statements of Income (Loss)
  77. [77] Item 8, Consolidated Statements of Income (Loss)
  78. [78] Item 8, Consolidated Statements of Income (Loss)
  79. [79] Item 8, Consolidated Statements of Income (Loss)
  80. [80] Item 8, Consolidated Statements of Income (Loss)
  81. [81] Item 7, MD&A — Results of Operations
  82. [82] Item 7, MD&A — Results of Operations
  83. [83] Item 8, Consolidated Statements of Cash Flows
  84. [84] Item 8, Consolidated Statements of Cash Flows
  85. [85] Item 8, Consolidated Balance Sheets
  86. [86] Item 8, Consolidated Balance Sheets
  87. [87] Item 1A, Risk Factors — Financial and Economic Risks
  88. [88] Item 7, MD&A — Results of Operations
  89. [89] Item 7, MD&A — Results of Operations
  90. [90] Item 7, MD&A — Results of Operations
  91. [91] Item 7, MD&A — Results of Operations
  92. [92] Item 7, MD&A — Results of Operations
  93. [93] Item 7, MD&A — Results of Operations
  94. [94] Item 7, MD&A — Results of Operations
  95. [95] Item 7, MD&A — Results of Operations
  96. [96] Item 7, MD&A — Results of Operations
  97. [97] Item 7, MD&A — Results of Operations
  98. [98] Item 7, MD&A — Results of Operations
  99. [99] Item 7, MD&A — Results of Operations
  100. [100] Item 7, MD&A — Segment Analysis
  101. [101] Item 7, MD&A — Segment Analysis

Analysis on 6/21/2026